Global Guillain-Barré Syndrome Market to Expand Amid Rising Cases, Advancements in Treatment, and Increasing Investments in Neurological Care
The Guillain-Barré Syndrome (GBS) market is experiencing significant growth, driven by rising cases, advancements in treatment, and increased investments. The market, valued at $591.2M in 2022, is expected to reach $960.58M by 2032 at a CAGR of 5.1%. Discover the latest trends and innovations in GBS treatment.